Optimising antifungal therapy for individual patients.

about

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.Antifungal guidelines.

P2860

Q33257899-7B2C98DD-A259-40F8-BE0B-CCCFFE2751E5 Q47608903-2ABFFAE5-D6F8-4609-859E-7696EC16FB2A

P2860

Optimising antifungal therapy for individual patients.

Item

http://www.wikidata.org/entity/Q44846156

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Optimising antifungal therapy for individual patients.

@en

Optimising antifungal therapy for individual patients.

@nl

type

Item

label

Optimising antifungal therapy for individual patients.

@en

Optimising antifungal therapy for individual patients.

@nl

prefLabel

Optimising antifungal therapy for individual patients.

@en

Optimising antifungal therapy for individual patients.

@nl

P1476

Optimising antifungal therapy for individual patients.

@en

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

Echinocandin antifungal drugs

The epidemiology of sepsis in the United States from 1979 through 2000

Mortality and costs of acute renal failure associated with amphotericin B therapy.

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.

P304

147-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1444-0903.2004.00569.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David W. Denning

William Hope

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15086692

http://www.w3.org/2001/XMLSchema#string

Optimising antifungal therapy for individual patients.

about

P2860

P2860

Optimising antifungal therapy for individual patients.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698